Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2021 07:30 ET | Source: InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™

VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...